Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
105.00    0.50 (0.48%)
Bid:
104.50
Ask:
107.00
Spread: 2.50 (2.392%)
Market Cap: £306.84m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

Litigation Update

21 Mar 2025 11:13

RNS Number : 7010B
Big Technologies PLC
21 March 2025
 

21 March 2025

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

Big Technologies plc

("Big Technologies" or the "Company" and the "Group")

Litigation Update

Further to the announcement released by the Company at 12:51 p.m. on 18 March 2025 (the "18 March Announcement"), the Company provides the following update on the Litigation (as defined in the 18 March Announcement) and other matters arising from its investigations. 

 

The Company's further investigations have resulted in the Board becoming aware of information which means that the Company can no longer rely on the statement signed by Sara Murray on behalf of the Company in the Litigation, where that relates to her interests in, and relationship with, Zinc Limited, Monitoring Partners Limited, RCP Limited and Romelle Limited. Together, these four entities held ordinary shares in the Company ("BIG Shares") at the time of the Company's Admission to AIM on 28 July 2021 ("Admission") representing approximately 17.7% of the issued share capital of the Company at that time.

 

As part of its continuing investigations, the Company has asked Sara Murray to clarify the exact nature of her interests in and relationship with the four entities referred to above.

Sarah Murray held BIG Shares at Admission representing approximately 25.3% of the Company's issued share capital at Admission. Since that time she has made a number of purchases of BIG Shares and has been issued further BIG Shares pursuant to the Company's Growth Share Plan, resulting in her current direct holding representing 26.8% of the current issued share capital of the Company.

 

In light of the information from its further investigations, the Company is considering its position in relation to the Litigation as well as other steps which it may be appropriate to take, including the possibility of claims or actions against and in relation to Sara Murray and others.

 

In the meantime, the company's investigations in relation to Sara Murray's conduct continue and the Company will provide further updates as appropriate. 

For further information please contact:

 

Big Technologies

+44 (0) 19 2360 1910

Alexander Brennan (Interim Chairman)

Daren Morris (Interim Chief Executive Officer)

Zeus (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDMZGZFMMZGKZM
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
30th Mar 20267:00 amRNSAudited Results for the year to 31 December 2025
26th Feb 20267:00 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSBoard Changes
2nd Feb 20267:00 amRNSHolding(s) in Company
27th Jan 20267:00 amRNSFull Year Trading Update
19th Jan 20267:00 amRNSFurther Litigation Update
10th Dec 20259:41 amRNSHolding(s) in Company
9th Dec 20259:42 amRNSHolding(s) in Company
8th Dec 20257:00 amRNSTrading Update
3rd Nov 20252:54 pmRNSDirector and PDMR Dealings
16th Oct 20257:01 amRNSWithdrawal of General Meeting Requisition Notice
16th Oct 20257:00 amRNSBoard Changes
3rd Oct 20257:00 amRNSBoard Changes
30th Sep 20257:00 amRNSInterim Results for the 6 months to 30 June 2025
26th Sep 20257:00 amRNSNotice of Requisition of a General Meeting
12th Sep 20257:00 amRNSLitigation Update
20th Aug 20257:00 amRNSChange of Website Address
6th Aug 20257:00 amRNSBoard Change and Issue of Shares
1st Aug 20257:00 amRNSIssue of Shares
28th Jul 20257:00 amRNSBoard Changes
22nd Jul 20257:00 amRNSTrading Update
18th Jun 20252:53 pmRNSResult of AGM and Litigation Update
13th Jun 20258:12 amRNSPublication of Letter to Shareholders
10th Jun 20251:27 pmRNSSuspension of Voting Rights and Letter Response
5th Jun 20257:00 amRNSLitigation Update
22nd May 20259:45 amRNSDirector Dealings
22nd May 20257:00 amRNS2024 Audited Results and Notice of AGM
16th May 20257:00 amRNSAppointment of Joint Corporate Broker
8th May 20257:00 amRNSBoard and Management Changes and Trading Update
7th Apr 20257:00 amRNSAppointment of Non Executive Director
3rd Apr 20257:00 amRNSUpdate re: CEO Dismissal
1st Apr 20257:00 amRNS-RContract Award
1st Apr 20257:00 amRNSDirectorate Change
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20255:20 pmRNSCEO Dismissal and Commencement of Litigation
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 202511:13 amRNSLitigation Update
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 202512:51 pmRNSCEO Suspension
18th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.